Glen Santangelo
Stock Analyst at Jefferies
(2.62)
# 2,254
Out of 5,053 analysts
78
Total ratings
48%
Success rate
3.89%
Average return
Main Sectors:
Stocks Rated by Glen Santangelo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HQY HealthEquity | Maintains: Buy | $130 → $134 | $99.83 | +34.23% | 6 | Sep 3, 2025 | |
| TDOC Teladoc Health | Maintains: Hold | $10 → $8 | $7.50 | +6.67% | 7 | Apr 21, 2025 | |
| ANIP ANI Pharmaceuticals | Initiates: Buy | $80 | $88.93 | -10.04% | 1 | Mar 14, 2025 | |
| VTRS Viatris | Maintains: Buy | $15 → $13 | $10.17 | +27.83% | 4 | Mar 7, 2025 | |
| WAY Waystar Holding | Initiates: Buy | $51 | $36.11 | +41.24% | 1 | Feb 11, 2025 | |
| XERS Xeris Biopharma Holdings | Reiterates: Buy | $4 → $6 | $7.72 | -22.28% | 2 | Jan 29, 2025 | |
| NVST Envista Holdings | Maintains: Hold | $20 → $22 | $20.05 | +9.73% | 1 | Jan 23, 2025 | |
| XRAY DENTSPLY SIRONA | Downgrades: Hold | $30 → $20 | $11.00 | +81.82% | 2 | Jan 23, 2025 | |
| PCRX Pacira BioSciences | Maintains: Buy | $15 → $18 | $23.07 | -21.98% | 5 | Sep 24, 2024 | |
| PGNY Progyny | Maintains: Buy | $31 → $24 | $23.62 | +1.61% | 4 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $14 → $23 | $41.05 | -43.97% | 4 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $23 | $24.26 | -5.19% | 4 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $41 → $44 | $43.53 | +1.08% | 3 | Jun 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $22.27 | -23.66% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $230 | $119.79 | +92.00% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $3.87 | +2,483.98% | 2 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $70 | $26.12 | +167.99% | 2 | Jul 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $55 | $32.43 | +69.60% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $13.73 | +16.53% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $46 | $52.54 | -12.45% | 2 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $31 → $28 | $2.85 | +882.46% | 2 | Mar 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $70 | $22.62 | +209.46% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $120 | $4.04 | +2,870.30% | 3 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $2 | $3.38 | -40.83% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $47 | $3.06 | +1,435.95% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $2.85 | +1,163.16% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $77.54 | - | 3 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $173 → $169 | $859.37 | -80.33% | 5 | May 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $205.43 | - | 4 | Dec 16, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $79 → $82 | $73.00 | +12.33% | 2 | Apr 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $250 | $138.23 | +80.86% | 1 | Dec 8, 2017 |
HealthEquity
Sep 3, 2025
Maintains: Buy
Price Target: $130 → $134
Current: $99.83
Upside: +34.23%
Teladoc Health
Apr 21, 2025
Maintains: Hold
Price Target: $10 → $8
Current: $7.50
Upside: +6.67%
ANI Pharmaceuticals
Mar 14, 2025
Initiates: Buy
Price Target: $80
Current: $88.93
Upside: -10.04%
Viatris
Mar 7, 2025
Maintains: Buy
Price Target: $15 → $13
Current: $10.17
Upside: +27.83%
Waystar Holding
Feb 11, 2025
Initiates: Buy
Price Target: $51
Current: $36.11
Upside: +41.24%
Xeris Biopharma Holdings
Jan 29, 2025
Reiterates: Buy
Price Target: $4 → $6
Current: $7.72
Upside: -22.28%
Envista Holdings
Jan 23, 2025
Maintains: Hold
Price Target: $20 → $22
Current: $20.05
Upside: +9.73%
DENTSPLY SIRONA
Jan 23, 2025
Downgrades: Hold
Price Target: $30 → $20
Current: $11.00
Upside: +81.82%
Pacira BioSciences
Sep 24, 2024
Maintains: Buy
Price Target: $15 → $18
Current: $23.07
Upside: -21.98%
Progyny
Sep 19, 2024
Maintains: Buy
Price Target: $31 → $24
Current: $23.62
Upside: +1.61%
Jun 27, 2024
Maintains: Hold
Price Target: $14 → $23
Current: $41.05
Upside: -43.97%
Jun 27, 2024
Maintains: Buy
Price Target: $19 → $23
Current: $24.26
Upside: -5.19%
Jun 7, 2024
Upgrades: Buy
Price Target: $41 → $44
Current: $43.53
Upside: +1.08%
Dec 19, 2023
Initiates: Buy
Price Target: $17
Current: $22.27
Upside: -23.66%
Dec 19, 2023
Assumes: Buy
Price Target: $230
Current: $119.79
Upside: +92.00%
Dec 15, 2023
Reiterates: Buy
Price Target: $100
Current: $3.87
Upside: +2,483.98%
Jul 25, 2023
Reinstates: Buy
Price Target: $70
Current: $26.12
Upside: +167.99%
Oct 21, 2022
Initiates: Hold
Price Target: $55
Current: $32.43
Upside: +69.60%
Oct 21, 2022
Initiates: Buy
Price Target: $16
Current: $13.73
Upside: +16.53%
May 18, 2022
Maintains: Buy
Price Target: $78 → $46
Current: $52.54
Upside: -12.45%
Mar 17, 2022
Upgrades: Buy
Price Target: $31 → $28
Current: $2.85
Upside: +882.46%
Dec 2, 2021
Initiates: Buy
Price Target: $70
Current: $22.62
Upside: +209.46%
Dec 2, 2021
Initiates: Hold
Price Target: $120
Current: $4.04
Upside: +2,870.30%
Dec 2, 2021
Initiates: Hold
Price Target: $2
Current: $3.38
Upside: -40.83%
Dec 2, 2021
Initiates: Buy
Price Target: $47
Current: $3.06
Upside: +1,435.95%
Dec 2, 2021
Initiates: Buy
Price Target: $36
Current: $2.85
Upside: +1,163.16%
Mar 17, 2021
Downgrades: Neutral
Price Target: n/a
Current: $77.54
Upside: -
May 21, 2020
Maintains: Hold
Price Target: $173 → $169
Current: $859.37
Upside: -80.33%
Dec 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $205.43
Upside: -
Apr 24, 2018
Maintains: Buy
Price Target: $79 → $82
Current: $73.00
Upside: +12.33%
Dec 8, 2017
Initiates: Hold
Price Target: $250
Current: $138.23
Upside: +80.86%